Korean Guidelines for the Pharmacological Treatment of Social Anxiety Disorder: Initial Treatment Strategies
- Authors
- Yoon, Hyungkun; Oh, Dong Jae; Suh, Ho-Suk; Lee, Kyoung-Uk; Lim, Se-Won; Lee, Jun-Yeob; Yang, Jong-Chul; Lee, Jae-Hon; Ha, Juwon; Lee, Bun-Hee; Kang, Seung-Gul; Yoon, Ho-Kyoung; Moon, Jihyun; Bae, Seung-Min; Kwon, Youngdo; Kim, Hyun-Chung; Oh, Kang Seob
- Issue Date
- 2월-2018
- Publisher
- KOREAN NEUROPSYCHIATRIC ASSOC
- Keywords
- Social anxiety disorder; Guideline; Initial treatment; Pharmacotherapy
- Citation
- PSYCHIATRY INVESTIGATION, v.15, no.2, pp.147 - 155
- Indexed
- SCIE
SSCI
SCOPUS
KCI
- Journal Title
- PSYCHIATRY INVESTIGATION
- Volume
- 15
- Number
- 2
- Start Page
- 147
- End Page
- 155
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/77890
- DOI
- 10.30773/pi.2017.05.01
- ISSN
- 1738-3684
- Abstract
- Objective The aim of the present study was to provide clinical consensus and evidence regarding initial treatment strategies for the pharmacological treatment of social anxiety disorder (SAD) in Korea. Methods We prepared a questionnaire to derive a consensus from clinicians regarding their preference for the pharmacological treatment of SAD in Korea. Data regarding medication regimens and psychotropic drugs used during initial treatment, the doses used, and the pharmacological treatment duration were obtained. Responses were obtained from 66 SAD experts, and their opinions were classified into three categories (first-line, second-line, third-line) using a chi-square analysis. Results Clinicians agreed upon first-line regimens for SAD involving monotherapy with selective serotonin reuptake inhibitors (SS-RIs) or the serotonin-norepinephrine reuptake inhibitor (SNRI) venlafaxine, or combined therapy using antidepressants with beta-blockers or benzodiazepines on a standing or as-needed basis. First-line psychotropic drug choices for initial treatment included the following: escitalopram, paroxetine, sertraline, venlafaxine, and propranolol. The medication dosage used by domestic clinicians was found to be comparable with foreign guidelines. Domestic clinicians tended to make treatment decisions in a shorter amount of time and preferred a similar duration of maintenance treatment for SAD when compared with foreign clinicians. Conclusion This study may provide significant information for developing SAD pharmacotherapy guidelines in Korea, especially in the early stage of treatment.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medical Science > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.